X
Xiaoqing Fan
Publications - 6
Citations - 6
Xiaoqing Fan is an academic researcher. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 1, co-authored 6 publications receiving 6 citations.
Papers
More filters
Journal ArticleDOI
Herbal formula BaWeiBaiDuSan alleviates polymicrobial sepsis-induced liver injury via increasing the gut microbiota Lactobacillus johnsonii and regulating macrophage anti-inflammatory activity in mice
Xiaoqing Fan,Chu-Tian Mai,Ling Zuo,Ju-Min Huang,Chun Xie,Ze-Bo Jiang,Run-Ze Li,Xiaojun Yao,Xing-Xing Fan,Qibiao Wu,Pei-Yu Yan,Liang Li,Jianxin Chen,Ying Xie,Elaine Lai-Han Leung +14 more
TL;DR: BaWeiBaiDuSan (BWBDS) was extracted from a formula of Panax ginseng C. A. Meyer, Lilium brownie F. E. Brown ex Miellez var. ex Redoute, Lonicera japonica Thunb, Hippophae rhamnoides Linn., Amygdalus Communis Vas, Platycodon grandiflorus (Jacq.) A. DC., and Cortex Phelloderdri as mentioned in this paper .
Journal ArticleDOI
Pharmacokinetics, absorption and transport mechanism for ginseng polysaccharides.
Juanhong Zhang,Jiaxin He,Ju-Min Huang,Xia Li,Xiaoqing Fan,Wenbin Li,Guofan Wu,Chun Xie,Xing-Xing Fan,Junmin Zhang,Xiaojun Yao,Rong Wang,Elaine Lai-Han Leung +12 more
TL;DR: In this article , the authors investigated the absorption pathways and mechanisms of Panax ginseng polysaccharide (GP) and found that the absorption of GAP was more than that of GP in rats after gavage administration, while there was no significant difference between both after intravenous administration.
Journal ArticleDOI
Clearance as an Early Indicator of Efficacy for Therapeutic Monoclonal Antibodies: Circumventing Dose Selection Challenges in Oncology
Chengcong Chen,Xiaoqing Fan,Lin Zhang,Peng Xu,Huixi Zou,Xing Zhao,Manish Gupta,Yanqin Feng,Xuesong Xu,Xiaoyu Yan +9 more
Journal ArticleDOI
Fate Determination Role of Erythropoietin and Romiplostim in the Lineage Commitment of Hematopoietic Progenitors
TL;DR: The data herein support that romiplostim in combination with EPO can treat EPO resistance and support an innovative combination therapy that further promotes erythropoiesis compared to EPO monotherapy and inhibits platelet production compared to romiplOSTim monotherapy.
Journal ArticleDOI
Scaling Pharmacodynamics from Rats to Humans to Support Erythropoietin and Romiplostim Combination Therapy to Treat Erythropoietin-Resistant Anemia
TL;DR: In this article , the authors performed interspecies pharmacodynamic scaling of recombinant human erythropoietin (rHuEPO) and romiplostim for human dose prediction.